MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH)

CUSIP: 57060U217

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / PHARMACEUTICAL
Total 13F shares
1,668,971
Share change
-412,321
Total reported value
$107,281,784
Price per share
$64.27
Number of holders
56
Value change
-$26,171,017
Number of buys
28
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 57060U217?
CUSIP 57060U217 identifies PPH - MARKET VECTORS ETF TR - PHARMACEUTICAL in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) as of Q4 2014

As of 31 Dec 2014, MARKET VECTORS ETF TR - PHARMACEUTICAL (PPH) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,668,971 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, Clal Insurance Enterprises Holdings Ltd, MORGAN STANLEY, HighTower Advisors, LLC, RAYMOND JAMES & ASSOCIATES, MACROVIEW INVESTMENT MANAGEMENT LLC, HOKANSON ASSOCIATES, INC., ENVESTNET ASSET MANAGEMENT INC, UNITED CAPITAL FINANCIAL ADVISERS, LLC, and CITIGROUP INC. This page lists 56 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.